Baidu
map

内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2018 AACE/ACE立场声明：骨骼健康中应用维生素和矿物质

2018-07-23 美国临床内分泌医师学会 Endocr Pract. 2018 Jul 23.

骨骼健康维生素矿物质

本文的主要目的是概述目前对最优营养的理解，最大限度地增加骨获益，减少骨丢失，降低脆性骨折的风险。

中文标题：

2018 AACE/ACE立场声明：骨骼健康中应用维生素和矿物质

英文标题：

THE USE OF VITAMINS AND MINERALS IN SKELETAL HEALTH: AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND THE AMERICAN COLLEGE OF ENDOCRINOLOGY (AACE/ACE) POSITION STATEMENT.

发布机构：

美国临床内分泌医师学会

发布日期：

2018-07-23

简要介绍：

本文的主要目的是概述目前对最优营养的理解，最大限度地增加骨获益，减少骨丢失，降低脆性骨折的风险。 

拓展指南：与维生素相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 AACE/ACE立场声明：骨骼健康中应用维生素和矿物质)] GetToolGuiderByIdResponse(projectId=1, id=b72791c001620206, title=2018 AACE/ACE立场声明：骨骼健康中应用维生素和矿物质, enTitle=THE USE OF VITAMINS AND MINERALS IN SKELETAL HEALTH: AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND THE AMERICAN COLLEGE OF ENDOCRINOLOGY (AACE/ACE) POSITION STATEMENT., guiderFrom=Endocr Pract. 2018 Jul 23., authorId=null, author=, summary=本文的主要目的是概述目前对最优营养的理解，最大限度地增加骨获益，减少骨丢失，降低脆性骨折的风险。 , cover=, journalId=null, articlesId=null, associationId=79, associationName=美国临床内分泌医师学会, associationIntro=美国临床内分泌医师协会是一家致力于内分泌学，糖尿病和代谢方面研究的专业医师协会，该机构努力提高其成员的能力以提供最高质量的患者护理。, copyright=0, guiderPublishedTime=Mon Jul 23 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>本文的主要目的是概述目前对最优营养的理解，最大限度地增加骨获益，减少骨丢失，降低脆性骨折的风险。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>维生素</font>相关指南：</strong><br><ul><li><a href="//m.sandwebs.com/guideline/show_article.do?id=8d4721c001592369" title="2018 意大利共识：儿童时期维生素D补充" target=_blank>2018 意大利共识：儿童时期维生素D补充</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=3837f1c001586618" title="2018 AME/AACE立场声明：成人维生素D缺乏的临床管理" target=_blank>2018 AME/AACE立场声明：成人维生素D缺乏的临床管理</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=575f61c00158311c" title="2018 USPSTF建议声明：补充维生素，钙或联合补充作为社区成人骨折的一级预防" target=_blank>2018 USPSTF建议声明：补充维生素，钙或联合补充作为社区成人骨折的一级预防</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=445b61c0015e2325" title="2018 EHRA实践指导：房颤患者应用非维生素K拮抗剂口服抗凝药" target=_blank>2018 EHRA实践指导：房颤患者应用非维生素K拮抗剂口服抗凝药</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=8cd911c001a544e3" title="2016 WAO麦克马斯特大学过敏性疾病预防指南：维生素D" target=_blank>2016 WAO麦克马斯特大学过敏性疾病预防指南：维生素D</a></li> 更多信息请点击：<a href="//m.sandwebs.com/guideline/list.do?q=%E7%BB%B4%E7%94%9F%E7%B4%A0" target=_blank>有关维生素更多指南</a></ul>, tagList=[TagDto(tagId=28472, tagName=骨骼健康), TagDto(tagId=1313, tagName=维生素), TagDto(tagId=14082, tagName=矿物质)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8713, appHits=192, showAppHits=0, pcHits=6858, showPcHits=2244, likes=190, shares=2, comments=8, approvalStatus=1, publishedTime=Thu Jul 26 23:00:39 CST 2018, publishedTimeString=2018-07-23, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Jul 26 23:00:39 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:05:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 AACE/ACE立场声明：骨骼健康中应用维生素和矿物质)])
2018 AACE/ACE立场声明：骨骼健康中应用维生素和矿物质
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=345784, encodeId=e38b345e8410, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Sep 20 08:40:58 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339149, encodeId=397033914933, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Aug 17 16:52:12 CST 2018, time=2018-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338500, encodeId=6e7433850068, content=学习并分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Aug 14 09:12:07 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338275, encodeId=ad643382e599, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Aug 13 07:31:02 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338143, encodeId=b6a9338143d5, content=学习并分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Aug 12 14:49:07 CST 2018, time=2018-08-12, status=1, ipAttribution=)]
    2018-09-20 大爰

    学习了谢谢分享！！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=345784, encodeId=e38b345e8410, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Sep 20 08:40:58 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339149, encodeId=397033914933, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Aug 17 16:52:12 CST 2018, time=2018-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338500, encodeId=6e7433850068, content=学习并分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Aug 14 09:12:07 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338275, encodeId=ad643382e599, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Aug 13 07:31:02 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338143, encodeId=b6a9338143d5, content=学习并分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Aug 12 14:49:07 CST 2018, time=2018-08-12, status=1, ipAttribution=)]
    2018-08-17 大爰

    学习了谢谢分享！！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=345784, encodeId=e38b345e8410, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Sep 20 08:40:58 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339149, encodeId=397033914933, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Aug 17 16:52:12 CST 2018, time=2018-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338500, encodeId=6e7433850068, content=学习并分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Aug 14 09:12:07 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338275, encodeId=ad643382e599, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Aug 13 07:31:02 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338143, encodeId=b6a9338143d5, content=学习并分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Aug 12 14:49:07 CST 2018, time=2018-08-12, status=1, ipAttribution=)]
    2018-08-14 大爰

    学习并分享！！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=345784, encodeId=e38b345e8410, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Sep 20 08:40:58 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339149, encodeId=397033914933, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Aug 17 16:52:12 CST 2018, time=2018-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338500, encodeId=6e7433850068, content=学习并分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Aug 14 09:12:07 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338275, encodeId=ad643382e599, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Aug 13 07:31:02 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338143, encodeId=b6a9338143d5, content=学习并分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Aug 12 14:49:07 CST 2018, time=2018-08-12, status=1, ipAttribution=)]
    2018-08-13 大爰

    学习了谢谢分享！！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=345784, encodeId=e38b345e8410, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Sep 20 08:40:58 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339149, encodeId=397033914933, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Aug 17 16:52:12 CST 2018, time=2018-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338500, encodeId=6e7433850068, content=学习并分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Aug 14 09:12:07 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338275, encodeId=ad643382e599, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Aug 13 07:31:02 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338143, encodeId=b6a9338143d5, content=学习并分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Aug 12 14:49:07 CST 2018, time=2018-08-12, status=1, ipAttribution=)]
    2018-08-12 大爰

    学习并分享！！

    0

Baidu
map
Baidu
map
Baidu
map